Abstract:Sudden cardiac death is one of the most important causes of death worldwide. Advancements in medical treatment, percutaneous interventions, and device therapy (ICD and CRTD) showed consistent reduction in mortality, mainly in survivors of SCD and in patients with ischemic cardiomyopathy and depressed left ventricular function. Patients with non-ischemic cardiomyopathies, mildly reduced LV function, and channelopathies have increased risk for SCD. Identifying the subgroup of these patients before they experience life-threatening or fatal events is essential to further improve outcomes. In this review, we aimed to summarize the current knowledge for risk stratification and primary prevention, to describe the gaps in evidence, and to discuss future directions for screening and treating patients at risk for SCD. PURPOSE OF REVIEW: The purpose of this review is to provide a comprehensive description of the etiologies of sudden cardiac death, risk stratification strategies, and to describe the current medical and interventional therapies. We aimed to discuss the current gaps in our knowledge of primary prevention of SCD and to review novel approaches and interventions. RECENT FINDINGS: The incidence of SCD has decreased in the last two decades due to improved pharmacological treatment and ICD implantation in SCD survivors and in patients with reduced left ventricular function and ischemic cardiomyopathy. The efficacy of ICD in patients with non-ischemic cardiomyopathy is challenged by new findings from the DANISH trial. Catheter ablation is new emerging strategy to prevent SCD in patients with scar relater or PVC-triggered ventricular arrhythmias. Despite the new treatments, SCD is still a major burden. ICD remains the cornerstone for patients with ischemic cardiomyopathy, whereas appropriate risk stratification of the patients with non-ischemic cardiomyopathy and channelopathies is needed to further improve outcomes. The future of ablation as the treatment and prevention of SCD remains to be studied.

Identification and management of high risk ventricular arrhythmias

Risk stratification and early prevention of malignant ventricular arrhythmia:rationale and design

The risk stratification in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Interpretation of 2015 European Society of Cardiology Guidelines for the Management of Ventricular Arrhythmias in Patients with Cardiomyopathies,Inherited Primary Arrhythmia Syndromes,paediatric Arrhythmias and Congenital Heart Disease, and the Prevention of Sudden Cardiac Death in Those Patients

Ventricular Arrhythmias in Ischemic Cardiomyopathy—New Avenues for Mechanism-Guided Treatment

Mechanistic and Therapeutic Perspectives for Cardiac Arrhythmias: Beyond Ion Channels

Sudden Cardiac Death in Hypertrophic Cardiomyopathy:Hig-risk Factors and Prevention

Advances in Research of Arrhythmogenic Right Ventricular Cardiomyopathy

Arrhythmias and Sudden Cardiac Death

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology …

Current Problems and Research Progress of Risk Stratification of Sudden Cardiac Death after Myocardial Infarc-tion

Indications of Implantable Cardioverter Defibrillator Therapy

Classification of Common Arrhythmias and Corresponding Treatment Principles in Communities

Progress in Investigations of Arrhythmias Originating in the Right Ventricle

For Whom the Bell Tolls : Refining Risk Assessment for Sudden Cardiac Death

Long-term outcomes in patients with arrhythmogenic right ventricular cardiomyopathy

Debate about Sudden Cardiac Death Resulting from Arrhythmias

Opportunities for sudden death prevention: Directions for new clinical and basic research

Primary Prevention of Sudden Cardiac Death Using Implantable Cardioverter Defibrillators

Machine learning techniques for arrhythmic risk stratification: a review of the literature

Ablation of the epicardial substrate in patients with long-QT syndrome at risk of sudden death